What Happened?
Emeryville, -based Zogenix Resigned Shawnte Mitchell as Executive Vice President, General Counsel and Corporate Secretary
About the Company
Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.
About the Person
Shawnte Mitchell is Chief Legal Officer and General Counsel at Genomatica. Previously, Shawnte held various senior legal leadership roles in the industry.
Info Source
News
Short Profile